Literature DB >> 15040889

Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer.

Jie Wang1, Yan Cai, Hao Xu, Jun Zhao, Xin Xu, Ya Ling Han, Zhi Xiong Xu, Bao Sheng Chen, Hai Hu, Min Wu, Ming Rong Wang.   

Abstract

Migration inhibitory factor-related protein 14 (MRP14) is one of calcium-binding proteins, referred as S100A9. The heterodimeric molecule formed by MRP14 with its partner MRP8 (S100A8) is the major fatty acid carrier in neutrophils. The MRP8/14 complex has been also implicated in the intracellular transport of arachidonic acid and its precursors in keratinocytes. We show here the involvement of MRP14 in human esophageal cancer. In an initial study, mRNA differential display-reverse transcription polymerase chain reaction (DD-PCR) was performed with two esophageal carcinomas, one esophageal adenocarcinoma and matched normal adjacent mucosa. DD-PCR with the arbitrary primer OPA3 showed that one cDNA band was highly expressed in normal tissues, but disappeared or substantially decreased in tumor counterparts. It was later identified to be the 3'-end of migration inhibitory factor-related protein 14 (MRP14). Northern blotting, RT-PCR and Western blotting corroborated the down-regulation of MRP14 in 58/64 squamous cell carcinomas and 2/2 adenocarcinomas as compared with adjacent normal epithelia of the esophagus. MRP14 was undetectable in 3/3 esophageal-carcinoma cell lines. Immunochemistry demonstrated that expression of MRP14 was restricted to normal esophageal epithelia. No mutation was found in the genomic DNA of the MRP14 gene by PCR and directed DNA sequencing. Our finding suggested that the reduction of MRP14 expression is a frequent event in Chinese human esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040889     DOI: 10.1038/sj.cr.7290201

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  18 in total

1.  S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells.

Authors:  Fengjin Qin; Yao Song; Zijian Li; Ling Zhao; Youyi Zhang; Li Geng
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

2.  Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.

Authors:  Hyeyeung Kim; Rong Wu; Kathleen R Cho; Dafydd G Thomas; Gabrielle Gossner; J Rebecca Liu; Thomas J Giordano; Kerby A Shedden; David E Misek; David M Lubman
Journal:  Proteomics Clin Appl       Date:  2008-03-07       Impact factor: 3.494

3.  S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.

Authors:  Emmanuel J Silva; Prokopios P Argyris; Xianqiong Zou; Karen F Ross; Mark C Herzberg
Journal:  Int J Biochem Cell Biol       Date:  2014-09-16       Impact factor: 5.085

Review 4.  Calprotectin and the Initiation and Progression of Head and Neck Cancer.

Authors:  P P Argyris; Z M Slama; K F Ross; A Khammanivong; M C Herzberg
Journal:  J Dent Res       Date:  2018-02-14       Impact factor: 6.116

5.  S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.

Authors:  Ashley N Reeb; Wen Li; Will Sewell; Laura A Marlow; Han W Tun; Robert C Smallridge; John A Copland; Kyle Spradling; Rebecca Chernock; Reigh-Yi Lin
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

6.  S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway.

Authors:  Saeid Ghavami; Iran Rashedi; Brian M Dattilo; Mehdi Eshraghi; Walter J Chazin; Mohammad Hashemi; Sebastian Wesselborg; Claus Kerkhoff; Marek Los
Journal:  J Leukoc Biol       Date:  2008-03-13       Impact factor: 4.962

Review 7.  Review of S100A9 biology and its role in cancer.

Authors:  Joseph Markowitz; William E Carson
Journal:  Biochim Biophys Acta       Date:  2012-11-01

8.  MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.

Authors:  Dipen M Maru; Rajesh R Singh; Christina Hannah; Constance T Albarracin; Yong X Li; Ronald Abraham; Angela M Romans; Hui Yao; Madan G Luthra; Sharmila Anandasabapathy; Stephen G Swisher; Wayne L Hofstetter; Asif Rashid; Rajyalakshmi Luthra
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

9.  Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer.

Authors:  Biao Fan; Lian-Hai Zhang; Yong-Ning Jia; Xi-Yao Zhong; Yi-Qiang Liu; Xiao-Jing Cheng; Xiao-Hong Wang; Xiao-Fang Xing; Ying Hu; Ying-Ai Li; Hong Du; Wei Zhao; Zhao-Jian Niu; Ai-Ping Lu; Ji-You Li; Jia-Fu Ji
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

10.  S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.

Authors:  Ali Khammanivong; Chengxing Wang; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.